Polycystic ovary syndrome (PCOS) is a common endocrine disorder, with complex etiology and pathophysiology, which remains poorly understood. It affects about 5-10% of women of reproductive age who typically suffer from obesity, hyperandrogenism, ovarian dysfunction, and menstrual irregularity. Indeed, PCOS is the most common cause of anovulatory infertility in industrialized nations, and it is associated with insulin resistance, type 2 diabetes mellitus, and increased cardiovascular risk. Although insulin resistance is not included as a criterion for diagnosis, it is a critical pathological condition of PCOS. The purpose of this systematic review is the analysis of recent randomized clinical trials of inositol(s) in PCOS, in particular myo- and D-chiro-inositol, in order to better elucidate their physiological involvement in PCOS and potential therapeutic use, alone and in conjunction with assisted reproductive technologies, in the clinical treatment of women with PCOS.

Effects of Inositol(s) in Women with PCOS: A Systematic Review of Randomized Controlled Trials / Unfer, Vittorio; Nestler, John E; Kamenov, Zdravko A; Prapas, Nikos; Facchinetti, Fabio. - In: INTERNATIONAL JOURNAL OF ENDOCRINOLOGY. - ISSN 1687-8337. - 2016:(2016), pp. 1-12. [10.1155/2016/1849162]

Effects of Inositol(s) in Women with PCOS: A Systematic Review of Randomized Controlled Trials

UNFER, VITTORIO;FACCHINETTI, Fabio
2016

Abstract

Polycystic ovary syndrome (PCOS) is a common endocrine disorder, with complex etiology and pathophysiology, which remains poorly understood. It affects about 5-10% of women of reproductive age who typically suffer from obesity, hyperandrogenism, ovarian dysfunction, and menstrual irregularity. Indeed, PCOS is the most common cause of anovulatory infertility in industrialized nations, and it is associated with insulin resistance, type 2 diabetes mellitus, and increased cardiovascular risk. Although insulin resistance is not included as a criterion for diagnosis, it is a critical pathological condition of PCOS. The purpose of this systematic review is the analysis of recent randomized clinical trials of inositol(s) in PCOS, in particular myo- and D-chiro-inositol, in order to better elucidate their physiological involvement in PCOS and potential therapeutic use, alone and in conjunction with assisted reproductive technologies, in the clinical treatment of women with PCOS.
2016
23-ott-2016
2016
1
12
Effects of Inositol(s) in Women with PCOS: A Systematic Review of Randomized Controlled Trials / Unfer, Vittorio; Nestler, John E; Kamenov, Zdravko A; Prapas, Nikos; Facchinetti, Fabio. - In: INTERNATIONAL JOURNAL OF ENDOCRINOLOGY. - ISSN 1687-8337. - 2016:(2016), pp. 1-12. [10.1155/2016/1849162]
Unfer, Vittorio; Nestler, John E; Kamenov, Zdravko A; Prapas, Nikos; Facchinetti, Fabio
File in questo prodotto:
File Dimensione Formato  
1849162.pdf

Open access

Tipologia: Versione pubblicata dall'editore
Dimensione 1.28 MB
Formato Adobe PDF
1.28 MB Adobe PDF Visualizza/Apri
Pubblicazioni consigliate

Licenza Creative Commons
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11380/1133381
Citazioni
  • ???jsp.display-item.citation.pmc??? 37
  • Scopus 101
  • ???jsp.display-item.citation.isi??? 76
social impact